carbidopa and Behavior Disorders

carbidopa has been researched along with Behavior Disorders in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corona-Morales, AA; Hernández, VS; Jáuregui-Huerta, F; Luquín, S; Medina, MP; Ruíz-Velasco, S; Zhang, L1
Belcastro, V; Calabresi, P; Castrioto, A; Gallina, A; Rossi, A; Tambasco, N1
Borison, RL; Giardina, WJ; Mosnaim, AD; Pedemonte, WA; Sabelli, HC; Vazquez, AJ1
Duvoisin, RC1
Goodgold, A; Jonas, S; Leibowitz, M; Lieberman, A1
Pfeiffer, R1

Reviews

2 review(s) available for carbidopa and Behavior Disorders

ArticleYear
Biochemical plasticity of synaptic transmission: a critical review of Dale's Principle.
    Biological psychiatry, 1976, Volume: 11, Issue:4

    Topics: 5-Hydroxytryptophan; Animals; Brain; Carbidopa; Deamination; Dihydroxyphenylalanine; Evoked Potentials; Humans; Mental Disorders; Methyldopa; Neural Inhibition; Neurons; Neurotransmitter Agents; Phenethylamines; Probenecid; Rabbits; Rats; Receptors, Drug; Synapses; Synaptic Transmission; Visual Perception

1976
Optimization of levodopa therapy.
    Neurology, 1992, Volume: 42, Issue:1 Suppl 1

    Topics: Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Interactions; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Levodopa; Mental Disorders; Sleep Wake Disorders

1992

Trials

1 trial(s) available for carbidopa and Behavior Disorders

ArticleYear
Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease.
    Neurology, 1975, Volume: 25, Issue:10

    Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Mental Disorders; Middle Aged; Movement Disorders; Parkinson Disease

1975

Other Studies

3 other study(ies) available for carbidopa and Behavior Disorders

ArticleYear
Dopamine receptor dysregulation in hippocampus of aged rats underlies chronic pulsatile L-Dopa treatment induced cognitive and emotional alterations.
    Neuropharmacology, 2014, Volume: 82

    Topics: Age Factors; Anhedonia; Animals; Antiparkinson Agents; Behavior, Animal; Carbidopa; Cognition Disorders; Drug Combinations; Emotions; Hippocampus; Levodopa; Male; Mental Disorders; Motor Activity; Neurons; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D5; Spatial Learning

2014
Levodopa-induced breathing, cognitive and behavioral changes in Parkinson's disease.
    Journal of neurology, 2011, Volume: 258, Issue:12

    Topics: Aged; Antiparkinson Agents; Carbidopa; Cognition Disorders; Drug Combinations; Humans; Levodopa; Male; Mental Disorders; Parkinson Disease; Respiration Disorders

2011
Problems in the treatment of Parkinsonism.
    Advances in experimental medicine and biology, 1977, Volume: 90

    Topics: Antiparkinson Agents; Arteriosclerosis; Carbidopa; Diagnosis, Differential; Drug Combinations; Eye Manifestations; Humans; Levodopa; Mental Disorders; Movement Disorders; Parasympatholytics; Paresthesia; Parkinson Disease; Vision Disorders

1977